Mays Cancer Center receives more than $10 million with NCI-Designated Cancer Center renewal
August 18, 2020This continues the Mays Cancer Center’s legacy as one of only four NCI-designated Cancer Centers in Texas and one of 71 in the U.S.
Mays Cancer Center receives more than $10 million with NCI-designated Cancer Center renewal
August 17, 2020SAN ANTONIO (Aug. 17, 2020) — The list of accomplishments and data supporting the renewal of the Mays Cancer Center as a National Cancer Institute-designated Cancer Center is impressive. 71% increase in peer-reviewed publications. 60% jump in research funding. Significant recruitment of women and Hispanics into cancer clinical trials. 60 new scientists recruited. $20.6 million renovation […]
Research shows new education program may increase hepatitis C screenings
August 10, 2020A team of researchers from UT Health San Antonio and UT Southwestern have published a study in the Journal of Cancer Education showing that a new, shortened training program for health care providers may increase screenings for hepatitis C virus (HCV) across the region.
UT Health San Antonio, University Hospital begin third remdesivir study
August 7, 2020San Antonio site was largest in the world for second study involving baricitinib SAN ANTONIO (Aug. 7, 2020) — UT Health San Antonio, with its clinical partner University Health System, are among the first study sites in the nation to begin the third phase of the COVID-19 clinical trial involving remdesivir. The Adaptive COVID-19 Treatment […]
Third remdesivir study begins
August 7, 2020UT Health San Antonio and its clinical partner University Health System are on the front lines working to find new treatments for COVID-19.
Ruben Mesa, MD, elected officer of Leukemia & Lymphoma Society Board
August 4, 2020Ruben Mesa, MD, FACP, has been elected an officer on the national board of the Leukemia & Lymphoma Society.